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Figure 1. MPA and MPA Analogs
Chemical structure of MPA and three analogs, along with IC50 values as reported in Syntex patents (Sjogen, 1995; Artis et al., 1995) . The IC 50 data are based on an in vitro assay that measures the formation of NADH by UV/VIS spectroscopy at 340 nm.
of IMPDH with proteins in the Protein Data Bank identithe second ␣ helix and third ␤ strand of the barrel. The subdomain has rough dimensions of 20 ϫ 20 ϫ 40 Å fied glycolate oxidase, tryptophan synthase, and indole-3-glycerol phosphate synthase as enzymes with similar and protrudes from the N-terminal side of the barrel core ( Figure 2 ). IMPDH is unique among ␣/␤ barrels in folds and C-terminal phosphate-binding sites. The closest known structural homolog to IMPDH is glycolate this regard. A comparison of IMPDH to aligned protein structures in the FSSP database (Holm and Sander, oxidase, with a backbone root-mean-square deviation of 1.49 Å over 172 residues. The sequence of glycolate 1996) located only 15 amino acids as the next largest insertion at the N-terminal end of any ␣/␤ barrel. In addioxidase also shows local homology to that of IMPDH, with 40% identity over 40 amino acids in the region tion, sequence comparisons identified GMP reductase as the closest IMPDH homolog, but the subdomain resisurrounding the phosphate-binding site.
The smaller flanking domain (designated subdomain dues are absent in this enzyme (Andrews and Guest, 1988) . The sequence and fold of the subdomain also here) includes residues 110-244 and is inserted between For definitions, see Blundell and Johnson (1976) .
(Figure 2 legend continued)
not visible in electron density maps are marked "???." The flap (residues 400-450) between strand ␤8 and helix ␣8 includes strands ␤J-␤N and helix ␣E. Residue assignments for the strands and helices that form the ␣/␤ barrel are as follows: ␤1, residues 65-68; ␣1, 76-85; ␤2, 88-91; ␣2, 98-109; ␤3, 245-250; ␣3, 256-266; ␤4, 270-274; ␣4, 281-293; ␤5, 298-302; ␣5, 307-316; ␤6, 320-324; ␣6, 343-355; ␤7, 360-364; ␣7, 370-378; ␤8, 382-386; and ␣8, 456-469 . Residue assignments for the remaining secondary structural elements are as follows: ␤A, residues 18-19; ␤B, 35-38; ␤C, 40-42; ␤D, 53-55; ␤E, 59-61; ␤F, 114-116; ␤G, 186-189; ␤H, 206-212; ␤I, 220-223; ␤J, 400-402; ␤K, 406-409; ␤L, 411-413; ␤M, 438-440; ␤N, 443-448; ␤O, 489-492; ␤P, 509-513; ␣A, 21-23; ␣B, 194-200; ␣C, 225-232; ␣D, 333-337; ␣E, 416-420; ␣F, 476-484; and ␣G, 495-501. (Carson, 1991) of IMPDH. The structure is viewed from the C-terminal end of the ␤ strands (yellow) that form the ␣/␤ barrel. The ␣ helices (red) on the outside of the barrel are labeled ␣1-␣8. The portion of the subdomain (orange) that is ordered is shown. Cys-331 (green) is labeled and sits over one end of the barrel. An arrow marks the location of the flap (residues 400-450) that, together with the active-site loop, helps form the active-site pocket.
(B) Topology diagram of the IMPDH fold. Secondary structure was assigned using the Kabsch and Sander algorithm (Kabsch and Sander, 1983) , along with visual inspection. The ␤ strands and ␣ helices that form the ␣/␤ barrel core are labeled ␤1-␤8 and ␣1-␣8. The strands and helices that are not part of the barrel are labeled ␤A-␤P and ␣A-␣G. Cys-331 is located on the loop between strand ␤6 and helix ␣D. The subdomain starts after helix ␣2 and ends at strand ␤3 and includes strands ␤F-␤I and helices ␣B and ␣C. Parts of the structure that were (Figure 2 legend continued on previous page) appeared to be novel, as no corresponding matches MPA is a potent (Ki ϭ 11 nM) uncompetitive inhibitor of Chinese hamster IMPDH, and the structure reveals could be found. The function of the subdomain in IMPDH is not known, and the structure reveals that this domain many interactions between MPA and IMPDH active-site residues ( Figure 4 ). One face of the bicyclic ring system is 35 Å away from the active site and is relatively disordered ( Figure 2 ). There is considerable variation in the is stacked on the XMP* hypoxanthine ring, while the other makes contact with the main-chain atoms of Sersize and sequence of this region among IMPDHs from different species, including Borrelia burgdorferi IMPDH 276. Together, the hexenoic acid tail, methyl substituent, and methoxy group of MPA make van der Waals con-(Genbank accession number U13372), which lacks most of the subdomain residues. A deletion mutant that retacts with the side-chain atoms of . Hydrogen places the entire subdomain in human type II IMPDH with a short peptide linker has been made, and the bonds (6) between the drug and IMPDH were also observed. These included hydrogen bonds between the truncated enzyme is fully active in vitro (our unpublished data).
O2 lactone oxygen and the amide nitrogen of Gly-326, and the C1 carbonyl oxygen and hydroxyl group of Thr-IMPDH is active in solution and crystallizes as a tetramer, and extensive contacts between barrels of adjacent 333. The hexenoic acid tail of MPA adopts a bent conformation, unlike the extended conformation seen in the monomers helped stabilize this form (Figure 3) . Most of the tetramer-related contacts arose from residues near nuclear magnetic resonance studies (Makara et al., 1996) and crystal structure of free MPA (Harrison et al., the N-and C-terminus of one subunit that contacted amino acids that were part of or near the active site 1972). This conformation allows the carboxylate group to form hydrogen bonds with the amide nitrogen and of an adjacent subunit. These interactions may help stabilize the active-site conformation. The subdomain side-chain hydroxyl groups of Ser-276. Additionally, the C7 phenolic oxygen forms hydrogen bonds to the sidemade no tetramer contacts.
chain hydroxyl group of Thr-333 and the side-chain amide of Gln-441.
The Active Site
We have determined the structure of IMPDH in complex with MPA and an IMP reaction intermediate that is genMutational and Kinetic Analysis of the Active Site erated during substrate turnover. In this inhibited state,
We generated a series of mutants to explore the roles hydride transfer and NADH release has occurred, but of human type II IMPDH active-site residues in catalysis XMP has not been produced (Link and Straub, 1996;  and inhibitor binding ( Figure 5 ). Knowledge of the threeFleming et al., 1996). Thus, MPA and an IMP intermediate dimensional structure permitted rationalization of the are bound in the active site simultaneously. This obserobserved phenotype. Mutation of either Cys-331 or Aspvation is consistent with the uncompetitive inhibition of 364 to Ala effectively abolished IMPDH activity relative IMPDH by MPA. The electron density in the active site to wild type. The crystal structure revealed that Cysclearly shows that a covalent bond is formed between 331 formed a covalent bond to XMP*, confirming its role the C2 carbon of IMP and the sulfur atom of Cys-331 in catalysis, while the side chain of Asp-364 formed a ( Figure 4 ) to yield an oxidized IMP thioimidate intermedihydrogen bond to the ribose moiety of XMP*. Changing ate (XMP*). Cys-331 has also been shown to form a Ser-329 to Ala reduced enzyme activity to 13% of the covalent bond with 14 C8-IMP when NAD is present wild-type level. This side chain formed a hydrogen bond (Huete-Perez et al., 1995; Link and Straub, 1996) . In to the phosphate of XMP*. Residues that made direct addition, Cys-331 forms a covalent bond to 6-Cl IMP contact with MPA were also modified. Substituting Thrand EICARMP, compounds which irreversibly inactivate 333 with Ile and Gln-441 with Ala increased the Ki ap-IMPDH (Antonino et al., 1994; Wang et al., 1996) . Toparent of MPA 300-fold and 25-fold, respectively. The gether, these observations establish an important role Thr-333→Ile mutation is of particular interest, since it for this residue in catalysis.
has been observed in murine blastoma cells selected In addition to the covalent bond to Cys-331, many for 10,000-fold increased resistance to MPA (Hodges, other interactions between XMP* and the enzyme were 1989; Lightfoot and Snyder, 1994) . The crystal structure observed (Figure 4) . The phosphate moiety forms hydroshowed a hydrogen bond network between Thr-333, gen bonds with four backbone amide nitrogen atoms Gln-441, and MPA, with the phenolic oxygen in particuand the side-chain hydroxyl groups of Tyr-411 and Serlarly good hydrogen bonding distance and geometry 329. Tyr-411 is located on one of a pair of ␤ strands with the side-chain hydroxyl of Thr-333 (see Figure 4 ). (residues 406-413 and 443-448) that are part of a flap
The carboxylate group of the hexenoic acid tail of MPA (residues 400-450) that makes three hydrogen bonds formed two hydrogen bonds with Ser-276. Mutating this with the hypoxanthine ring. Together, these interactions residue to Ala disrupted this interaction and led to a may help order this region of IMPDH. This hypothesis 7-fold increase in Ki apparent. In contrast, mutations of is supported by proteolysis experiments that show that other active-site residues, such as Ser-275, Ser-327, IMPDH is protected from cleavage by elastase after and Gln-368, had little effect on catalytic activity or drug residues 437 and 440 when IMP is present (Nimmesgern inhibition. The structure indicates that these residues et al., submitted). The ribose ring, which adopts a C3Ј-do not contact substrate or inhibitor directly. endo conformation, also contributes significantly to binding. The structure shows that the O2Ј and O3Ј hydroxyl groups form a hydrogen-bonding network to Ser-IMPDH Dependence on Potassium Kinetic experiments with human IMPDH reveal that, al-68 and Asp-364. Van der Waals contacts between XMP*, Met-70, and Ile-330 were also observed.
though IMP can bind to the enzyme in the absence of potassium, this ion is required for the reaction to proresidues near the C-terminus of an adjacent IMPDH subunit, suggesting that potassium may also stabilize the ceed (Xiang et al., 1996) . The structure explains this observation. We observed a large peak in difference tetramer form of IMPDH (see Figure 3) . electron-density maps that was surrounded by a water molecule and five main-chain carbonyl oxygens, includDiscussion ing that of Cys-331 (data not shown). The average distance of the peak center to each of the surrounding Proliferating B and T lymphocytes are singularly dependent on the de novo, as opposed to salvage, pathway ligands was 3.1 Å , and the peak was hexagonally coordinated. The nature and positioning of the ligands sugfor purine biosynthesis. Inhibitors of IMPDH, which catalyzes the rate-limiting step in the de novo synthesis gested a potassium-binding site. Thus, potassium may organize protein conformation around the active site of guanosine nucleotides, have been shown to have a strong immunosuppressive effect. One such compound and could help position Cys-331 for catalysis. In addition, three of the carbonyl oxygen ligands resided on is MPA. The ternary complex described here reveals (Carson, 1991) . Refined coordinates of the IMP thioimidate intermediate and MPA are shown in thick bonds superimposed on the SigmaA-weighted (Read, 1986) 2Fobs-Fcalc electron density contoured at 2.0 . Carbon atoms are green, nitrogen atoms blue, oxygen red, sulfur yellow, and phosphorous purple. The hypoxanthine ring makes a covalent bond to the sulfur of Cys-331. Side chains that interact with substrate or inhibitor to form the active-site pocket are shown using thin bonds. These interactions should also apply to the human type II form of IMPDH. There are only six differences in amino acid sequence between Chinese hamster and human type II IMPDH (R173C, N215D, L265Q, M290I, E292D, and C327S). These side chains are all at least 15 Å away from the active site, except C327S, which is a conservative mutation and points away from the active-site pocket.
(B) Schematic representation of the XMP*-IMPDH interactions. There is a covalent bond between the sulfur atom of Cys-331 and the C2 carbon of the hypoxanthine ring. (C) Schematic representation of the MPA-IMPDH interactions. All proximal water molecules observed in electron density difference maps are labeled "H 2O." All distances pertain to nonhydrogen atoms. much about the structure and mechanism of IMPDH and nicotinamide ring and the bound substrate, and as observed in the structures of glutathione reductase and provides atomic level details of an immunosuppressant inhibiting its cellular target.
NADH peroxidase. It is also known that hydride transfer occurs on the ␤ face of NAD (Cooney et al., 1987) . If no large conformational changes occur between the time Enzymatic Mechanism of IMPDH NADH leaves and MPA binds, these structural considerand Inhibition by MPA ations support an earlier prediction (Hedstrom and The IMPDH catalyzed oxidation of IMP results in transfer Wang, 1990 ) that during hydride transfer the nicotinof hydrogen to the nicotinamide ring of NAD, forming amide of NAD occupies a position similar to the 6,5 ring NADH and XMP. Since direct transfer of the hydride system of MPA. In this orientation, the nicotinamide is energetically unfavorable, two mechanisms involving amide moiety would form hydrogen bonds with Gly-324, activation of IMP at the inosine C2 position have been Thr 333, Gly-326, and Asn-303. proposed (Hedstrom and Wang, 1990) . In the first mech-
The structure of the inhibited complex also indicates anism, water, aided by an active-site base to provide that the phenolic hydroxyl group of MPA, which forms OH Ϫ attack, is added in an initial step at C2. Hydride hydrogen bonds to Thr-333 and Gln-441, may be a retransfer to NAD then occurs from the tetrahedral interplacement for the catalytic water that hydrolyzes the mediate thus formed, producing the enol tautomer of thioimidate intermediate to produce XMP. In the ab-XMP. In the second mechanism, nucleophilic attack on sence of MPA, a water molecule in the vicinity of the IMP occurs from an active-site cysteine thiol. This is MPA hydroxyl would be stabilized by hydrogen bonds followed by hydride transfer to NAD to yield a covalently with Thr-333 and Gln-441 and would be properly posibound thioimidate intermediate that is hydrolyzed to tioned for nucleophilic attack at the C2 carbon of the XMP in a subsequent step. The crystal structure, in comthioimidate intermediate. Therefore, structural features bination with recent results that also demonstrate the of the bound orientation of MPA indicate that it is both formation of an IMPDH-substrate covalent adduct a nicotinamide ring and a catalytic water mimic. This (Huete-Perez et al., 1995; Link and Straub, 1996) , hypothesis is consistent with a report that des-hydroxystrongly supports the second mechanism. The direct MPA is at least 1000-fold less potent in a cellular assay observation of the covalently bound thioimidate as the than MPA (Or et al., 1995, Am. Chem. Soc., poster). It oxidized IMP intermediate confirms that enzyme-catahas also been shown that the presence of a hydroxyl lyzed oxidation of IMP occurs via attack of Cys-331 at group which is able to mimic a catalytic water molecule the C2 position and excludes a general base mechanism can lead to as much as a 10 kcal/mol improvement in where water is added to the inosine ring in an early step.
binding (Wolfendon and Kati, 1991) . Additional activeOther aspects of the IMPDH catalyzed reaction can site mutants, coupled with substrate and MPA analog be addressed with the crystal structure. Although the studies underway, will test these hypotheses. MPA inhibited complex does not contain NAD or NADH, a combination of structural and chemical evidence Inhibition of IMPDH by Analogs of MPA allows the nicotinamide ring to be modeled into the The crystal structure of the MPA-inhibited complex active site. The nicotinamide ring must be oriented to helps to explain some of the known structure-activity allow hydride transfer from the C2 position of IMP to data for analogs of MPA (Figure 1 ), which also bind as the C4 position of NAD. Further, hydride transfer occurs uncompetitive inhibitors (data not shown). Replacement more readily if the nicotinamide and hypoxanthine rings of the phenolic hydroxyl by amino leads to an 8-fold are nearly parallel , consistent with the reduction in potency (Sjogen, 1995) . The structure indicates that this change would result in the loss of one favorable interactions provided by stacking between the hydrogen bond in the network between MPA, Thr-333, site contains an IMP intermediate covalently linked to Cys-331, which confirms the correct enzymatic mechaand Gln-441 (Figure 4 ). More dramatic changes to the hydroxyl group that increase the steric bulk can reduce nism for IMPDH. The structure also indicates that MPA inhibits the enzyme by simultaneously mimicking the potency by 1000-fold or more (Sjogen, 1995) . The portion of the active site that surrounds the phenolic hynicotinamide portion of the NAD cofactor and a catalytic water molecule. We observe K ϩ ion bound near the droxyl group is tightly packed and cannot accommodate additional atoms. Significant variations in potency are active site and tetramer interface, which explains the dependence on this cation for enzyme activity. Further, also seen in MPA analogs that alter the hexenoic acid side chain. Reduction of the carboxylate group to the we find that IMPDH contains a unique phosphate-binding site, which reveals in part the specificity of MPA for alcohol, or esterification, leads to a 50-fold reduction in IMPDH inhibition (D. Armistead, unpublished data).
IMPDH versus other NAD-binding enzymes. The structural information should facilitate the develThese changes would interfere with hydrogen bonding to Ser-276. Examples of constrained side-chain comopment of more efficacious IMPDH inhibitors that address the limitations of MPA. Mycophenolate mofetil pounds that are more potent in vitro IMPDH inhibitors than MPA have been disclosed (Artis et al., 1995) . Ab (CellCept TM ), a prodrug of MPA which quickly liberates free MPA in vivo, is an effective immunosuppressant initio and molecular dynamics calculations indicate that many of these analogs have low-energy conformations available for the prevention of rejection following kidney transplantation (Shaw et al., 1995; . Sevthat preserve the hydrogen bonds with Ser-276 while reducing the entropy of the hexenoic acid side chain.
eral clinical observations, however, limit the therapeutic potential of this drug (Shaw et al., 1995) . MPA is rapidly metabolized to the glucuronide in vivo, which then unSimilarity of IMPDH to Other Enzymes dergoes enterohepatic recycling (Allison and Eugui, Insight into the structure and mechanism of related en-1993) . This metabolic profile leads to accumulation of zymes is revealed in part by the IMPDH structure. Sedrug substance in the gastrointestinal tract (Shaw et al., quence database searching identified GMP reductase 1995; P. Chaturvedi, unpublished data), thereby lowas the closest IMPDH homolog, with 63% similarity and ering the in vivo potency and contributing to gastrointes-37% identity over a region of 150 amino acids that intinal side effects. Novel IMPDH inhibitors designed in cluded the active-site cysteine as well as the phosphate part from the structural information presented here may binding site. The high level of sequence conservation result in improved therapeutics for use in cancer and around the active site suggests that GMP reductase has immunosuppressive chemotherapy. a similar fold and active-site geometry to IMPDH. This is supported by the observation that GMP reductase,
Experimental Procedures
like IMPDH, binds substrate before cofactor (Spector et al., 1979) .
Crystallization and Data Collection
The structure of the IMPDH ␣/␤ barrel is similar to Details of sample preparation for crystallization are described elsewhere (Fleming et al., 1996) to be less specific than MPA.
The program PHASES (Furey and Swaminathan, 1996) was used for all heavy-atom parameter refinement, multiple isomorphous replacement phasing, solvent flattening, and phase combination. Ow-
Conclusion
ing to overlap of heavy atom sites between derivatives and a sharp
We have determined the high resolution crystal structure increase in nonisomorphism, data beyond 4 Å was not helpful for initial multiple isomorphous replacement phasing. The overall mean of IMPDH in complex with an IMP reaction intermediate MPA is the active metabolite of a recently approved (Brunger, 1993) , simulated annealing, and torsional dynamics (Rice immunosuppressive drug. The structure reveals atomic and Brunger, 1994) , were used to complete refinement of the struclevel details of the enzymatic mechanism of IMPDH and ture. Although the presence of the subdomain (residues 110-244) in the crystals has been confirmed by gel analysis, electron density the nature of the inhibition of IMPDH by MPA. The active
